329 related articles for article (PubMed ID: 33013366)
1. The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer.
Piesche M; Roos J; Kühn B; Fettel J; Hellmuth N; Brat C; Maucher IV; Awad O; Matrone C; Comerma Steffensen SG; Manolikakes G; Heinicke U; Zacharowski KD; Steinhilber D; Maier TJ
Front Pharmacol; 2020; 11():1297. PubMed ID: 33013366
[TBL] [Abstract][Full Text] [Related]
2. Structural Modifications Yield Novel Insights Into the Intriguing Pharmacodynamic Potential of Anti-inflammatory Nitro-Fatty Acids.
Hellmuth N; Brat C; Awad O; George S; Kahnt A; Bauer T; Huynh Phuoc HP; Steinhilber D; Angioni C; Hassan M; Hock KJ; Manolikakes G; Zacharowski K; Roos J; Maier TJ
Front Pharmacol; 2021; 12():715076. PubMed ID: 34867322
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory nitro-fatty acids suppress tumor growth by triggering mitochondrial dysfunction and activation of the intrinsic apoptotic pathway in colorectal cancer cells.
Kühn B; Brat C; Fettel J; Hellmuth N; Maucher IV; Bulut U; Hock KJ; Grimmer J; Manolikakes G; Rühl M; Kühn A; Zacharowski K; Matrone C; Urbschat A; Roos J; Steinhilber D; Maier TJ
Biochem Pharmacol; 2018 Sep; 155():48-60. PubMed ID: 29909078
[TBL] [Abstract][Full Text] [Related]
4. Electrophilic nitrated fatty acids are potential therapeutic candidates for inflammatory and fibrotic lung diseases.
Panati K; Thimmana LV; Narala VR
Nitric Oxide; 2020 Sep; 102():28-38. PubMed ID: 32574817
[TBL] [Abstract][Full Text] [Related]
5. Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418.
Maucher IV; Rühl M; Kretschmer SB; Hofmann B; Kühn B; Fettel J; Vogel A; Flügel KT; Manolikakes G; Hellmuth N; Häfner AK; Golghalyani V; Ball AK; Piesche M; Matrone C; Geisslinger G; Parnham MJ; Karas M; Steinhilber D; Roos J; Maier TJ
Biochem Pharmacol; 2017 Feb; 125():55-74. PubMed ID: 27823964
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs Bioactivated to Quinones Target NF-κB and Multiple Protein Networks: Identification of the Quinonome.
Pierce EN; Piyankarage SC; Dunlap T; Litosh V; Siklos MI; Wang YT; Thatcher GR
Chem Res Toxicol; 2016 Jul; 29(7):1151-9. PubMed ID: 27258437
[TBL] [Abstract][Full Text] [Related]
7. Nitro-fatty acids: formation, redox signaling, and therapeutic potential.
Trostchansky A; Bonilla L; González-Perilli L; Rubbo H
Antioxid Redox Signal; 2013 Oct; 19(11):1257-65. PubMed ID: 23256873
[TBL] [Abstract][Full Text] [Related]
8. Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs).
Roskoski R
Pharmacol Res; 2021 Mar; 165():105422. PubMed ID: 33434619
[TBL] [Abstract][Full Text] [Related]
9. The role of nitrated fatty acids and peroxisome proliferator-activated receptor gamma in modulating inflammation.
Narala VR; Subramani PA; Narasimha VR; Shaik FB; Panati K
Int Immunopharmacol; 2014 Nov; 23(1):283-7. PubMed ID: 25241247
[TBL] [Abstract][Full Text] [Related]
10. Nitro Fatty Acids (NO
Koutoulogenis GS; Kokotos G
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946618
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
12. The discovery of nitro-fatty acids as products of metabolic and inflammatory reactions and mediators of adaptive cell signaling.
Freeman BA; O'Donnell VB; Schopfer FJ
Nitric Oxide; 2018 Jul; 77():106-111. PubMed ID: 29742447
[TBL] [Abstract][Full Text] [Related]
13. Nitrated fatty acids in cardiovascular diseases.
Mollenhauer M; Mehrkens D; Rudolph V
Nitric Oxide; 2018 Mar; ():. PubMed ID: 29588164
[TBL] [Abstract][Full Text] [Related]
14. Michael acceptor molecules in natural products and their mechanism of action.
Liang ST; Chen C; Chen RX; Li R; Chen WL; Jiang GH; Du LL
Front Pharmacol; 2022; 13():1033003. PubMed ID: 36408214
[No Abstract] [Full Text] [Related]
15. Kinetics and Thermodynamics of Reversible Thiol Additions to Mono- and Diactivated Michael Acceptors: Implications for the Design of Drugs That Bind Covalently to Cysteines.
Krenske EH; Petter RC; Houk KN
J Org Chem; 2016 Dec; 81(23):11726-11733. PubMed ID: 27934455
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory signaling and metabolic regulation by nitro-fatty acids.
Rom O; Khoo NKH; Chen YE; Villacorta L
Nitric Oxide; 2018 Mar; ():. PubMed ID: 29578057
[TBL] [Abstract][Full Text] [Related]
17. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.
Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH
Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529
[TBL] [Abstract][Full Text] [Related]
18. Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.
Jones RD; Liao J; Tong X; Xu D; Sun L; Li H; Yang GY
Front Pharmacol; 2019; 10():731. PubMed ID: 31293429
[TBL] [Abstract][Full Text] [Related]
19. Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
Jackson PA; Widen JC; Harki DA; Brummond KM
J Med Chem; 2017 Feb; 60(3):839-885. PubMed ID: 27996267
[TBL] [Abstract][Full Text] [Related]
20. Post-Translational Modification of Proteins Mediated by Nitro-Fatty Acids in Plants: Nitroalkylation.
Aranda-Caño L; Sánchez-Calvo B; Begara-Morales JC; Chaki M; Mata-Pérez C; Padilla MN; Valderrama R; Barroso JB
Plants (Basel); 2019 Mar; 8(4):. PubMed ID: 30934982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
